Telix Pharmaceuticals Limited filed a 'Convertible Bond Cleansing Notice' with the Australian Securities Exchange on April 20, 2026, attached as Exhibit 99.1 to this Form 6-K.
Key takeaways
Filed announcement titled 'Convertible Bond Cleansing Notice' with ASX on April 20, 2026 (Melbourne time).
Announcement attached as Exhibit 99.1 to Form 6-K.
Serves as cleansing notice, likely related to convertible bond issuance or securities placement under Australian rules.
Signed by Christian Krautkramer, Group General Counsel, on April 20, 2026.